Product Information
CANDESARTAN CILEXETIL 32 MG TB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5189 per EA under NDC 62332006090. Its NADAC has been published 478 times since Aug 9, 2017.
FDA first approved this application on Jun 20, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
32 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332006090
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CANDESARTAN CILEXETILApproval Type
Generic (ANDA)
FDA Application
ANDA209119FDA Approved
6/20/2017
TE Code
AB
On Market Since
6/21/2017
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN CILEXETIL 32 MG TB has been published 478 times since Aug 9, 2017, and over the history we have for it it has declined 78.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5189 per EA |
|---|---|
| All-time high | $2.4927 (Sep 13, 2017) |
| All-time low | $0.5107 (Aug 19, 2026) |
| 52-week high | $0.6049 |
| 52-week low | $0.5107 |
| Median price | $1.1047 |
| Average price | $1.1905 |
| Largest weekly change | -34.5% (Nov 20, 2024) |
| Weeks tracked | 478 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CANDESARTAN CILEXETIL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CANDESARTAN CILEXETIL 32 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN CILEXETIL 32 MG TB, manufactured by Alembic Pharmaceuticals Inc., is $0.5189 per EA (NDC 62332006090), effective Sep 30, 2026.
How has the price of CANDESARTAN CILEXETIL 32 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN CILEXETIL 32 MG TB has declined 78.2%. It has been tracked across 478 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for CANDESARTAN CILEXETIL 32 MG TB?
Since Aug 9, 2017, the NADAC for CANDESARTAN CILEXETIL 32 MG TB has ranged from a low of $0.5107 (Aug 19, 2026) to a high of $2.4927 (Sep 13, 2017), with a median of $1.1047 per EA.
Are there cheaper alternatives to CANDESARTAN CILEXETIL 32 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN CILEXETIL 32 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN CILEXETIL 32 MG TB?
CANDESARTAN CILEXETIL 32 MG TB (NDC 62332006090) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.